- Home
- SMG vs CNTA Comparison
SMG vs CNTA Comparison
Compare SMG & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SMG | CNTA |
|---|---|---|
| Founded | 1868 | 2020 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Agricultural Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.5B |
| IPO Year | 2012 | 2021 |
Fundamental Metrics
Financial Performance| Metric | SMG | CNTA |
|---|---|---|
| Price | $65.79 | $26.57 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 9 |
| Target Price | ★ $72.33 | $40.89 |
| AVG Volume (30 Days) | 769.7K | ★ 1.1M |
| Earning Date | 04-29-2026 | 05-13-2026 |
| Dividend Yield | ★ 4.24% | N/A |
| EPS Growth | ★ 504.92 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,016,500,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.54 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 6.17 | N/A |
| 52 Week Low | $45.61 | $9.60 |
| 52 Week High | $72.35 | $30.58 |
Technical Indicators
Market Signals| Indicator | SMG | CNTA |
|---|---|---|
| Relative Strength Index (RSI) | 52.72 | 49.00 |
| Support Level | $57.59 | $24.62 |
| Resistance Level | $71.16 | $30.29 |
| Average True Range (ATR) | 2.30 | 1.42 |
| MACD | -0.13 | -0.08 |
| Stochastic Oscillator | 61.33 | 34.75 |
Price Performance
Historical ComparisonAbout SMG Scotts Miracle-Gro Company (The)
Scotts Miracle-Gro is the largest purveyor of home lawn and gardening products in the US. The company sells a broad range of lawncare products, including grass seed, fertilizer, and lawn-related weed, animal, and disease control. US consumer typically generates the vast majority of companywide revenue and profits. Its lawncare and gardening products are well-recognized brands in the US, including Scotts, Miracle-Gro, Roundup, Ortho, and Tomcat.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.